In Case You Missed It: Innovation's Impact

In Case You Missed It: Innovation's Impact

02.15.13 By Christian Clymer

On Tuesday during the State of the Union, President Obama said, “Now is not the time to cut…job-creating investments in science and innovation.” Prior to the State of the Union, our President and CEO John J. Castellani also addressed innovation, noting that the decisions we make now as they relate to health care “will directly affect our ability to deliver a healthy and innovative future.” This week on The Catalyst, we emphasized the kind of impact the biopharmaceutical sector can have on innovation.

Innovation Helps Patients

post this week by Rick Smith discussed a recent study as just one example of the fast-paced science that is enabling cutting-edge biopharmaceutical innovation. The study unveiled the genetic mechanisms of a particularly challenging form of breast cancer that doesn’t respond to available treatments. For many of those patients, the prognosis with existing medicines is grim.  Identifying five new genetic markers holds promise for developing new medicines.

Another post on The Catalyst  highlighted a new report on the positive impact biopharmaceutical companies and their local research collaborators in Virginia have on patients. The report found that 3,412 clinical trials of new medicines have been conducted in Virginia since 1999.Virginia Governor Robert McDonnell applauded the fact that 46 percent of those– over 1,500 –targeted the nation’s six most debilitating chronic diseases – asthma, heart disease, stroke, cancer, diabetes and mental illnesses.

Innovation Creates Jobs

Additionally, Governor McDonnell addressed how the research and biopharmaceutical industries have helped the state’s economy. He said clinical trials "support jobs and inject revenue into our communities," emphasizing that the biopharmaceutical sector supports approximately 76,000 jobs throughout Virginia.

The industry will continue to invest heavily in innovative R&D because it creates jobs and helps people live longer, healthier lives.

We look forward to sharing more stories about how innovation in the biopharmaceutical sector helps patients and creates jobs. We encourage you to leave your comments and check The Catalyst regularly for additional industry updates.



Hide Comments

More On PhRMA — powered by PhRMApedia


Cost in Context